Complete disappearance of ER+/HER2+ breast cancer xenografts with the combination of gefitinib, trastuzumab and pertuzumab to block HER2 cross-talk with ER and restore tamoxifene inhibition / DE PLACIDO, Sabino. - (2005).
Complete disappearance of ER+/HER2+ breast cancer xenografts with the combination of gefitinib, trastuzumab and pertuzumab to block HER2 cross-talk with ER and restore tamoxifene inhibition.
DE PLACIDO, SABINO
2005
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


